CVE-2026-105793: fallo crítico en microsoft UFO
Microsoft UFO: Authenticated Android shell command injection in Mobile MCP `press_key`
Publicada el
Aviso por correo cuando entre en el KEV, tenga PoC pública o suba de nota.
28Vexday Risk Score
Sin señal de explotación. Ningún artefacto público de explotación conocido hasta ahora.
ssvc Trackcvss 9.1epss 0.9%
Microsoft UFO is an open-source framework for intelligent automation across devices and platforms. Prior to 3.0.9, the press_key tool in ufo/client/mcp/http_servers/mobile_mcp_server.py accepts a free-form key_code parameter and passes it to `adb shell input keyevent`. The adb client joins the arguments into a remote command string that the Android shell reparses, allowing an authenticated Mobile MCP caller to execute additional commands as the Android shell user on an authorized connected device. Exploitation requires a valid UFO_MCP_API_KEY, adb on the host, and a reachable authorized device, and it does not establish host operating-system execution, Android root execution, or access beyond the Android shell-user privileges. This issue is fixed in version 3.0.9.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:L
Productos afectados
microsoft · UFOCVEs relacionadas — microsoft UFO
En el mismo producto, de las más peligrosas a las menos.
CVE-2026-73296CRITICALMicrosoft UFO: Unauthenticated Mobile MCP access allows remote Android device control and screen disclosureEPSS 3.7%CVE-2026-73297MEDIUMMicrosoft UFO: IPv6 transition address bypass of SSRF guard in URL validationEPSS 2.9%CVE-2026-45322HIGHOS Command Injection in Microsoft UFO Shell Action Replay via Stored Session JSONEPSS 2.4%CVE-2026-105788HIGHMicrosoft UFO: Authenticated Android shell command injection in Mobile MCP type_text and launch_appEPSS 1.1%CVE-2026-46402HIGHMicrosoft UFO uses untrusted task_name in log paths, allowing authenticated path traversal and log file creation outside the logs directoryEPSS 0.7%CVE-2026-105791HIGHMicrosoft UFO: Arbitrary code execution in `run_shell` via `explorer.exe` argument injectionEPSS 0.7%